GlassScriptPhysician profile
Joseph Frank Stella
NPI 1104880376
$8,867.07
in general payments reported to CMS, 2019-2025
41 companies · $2,505 in 2025
The $2,505 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $690 · 2021: $820 · 2022: $905 · 2023: $1,313 · 2024: $1,532 · 2025: $2,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,342 · Education: $9.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,341.55 |
| Education | $9.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,375.73 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,144.59 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $1,096.50 | 2019-2025 | |
| Aop Health US, LLC | $1,063.44 | 2025 | Rapiblyk |
| Janssen Pharmaceuticals, INC | $794.72 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $535.65 | 2021-2025 | Lifevest |
| Amgen INC. | $469.95 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $269.34 | 2019-2024 | Farxiga, Wainua, Andexxa |
| Medtronic, INC. | $249.82 | 2021-2024 | Cobalt Dr Mri Surescan |
| Novo Nordisk INC | $199.48 | 2019-2025 | Wegovy, Ozempic |
| Chiesi USA, INC. | $159.75 | 2019-2021 | |
| Boston Scientific Corporation | $136.80 | 2021-2025 | Bodyguardian, Watchman Flx |
| Medtronic Vascular, INC. | $128.24 | 2020 | |
| Kestra Medical Technology Services, INC. | $119.50 | 2022-2024 | Assure Wcd |
| Scpharmaceuticals INC. | $91.48 | 2023-2024 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Stella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.